Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Targeted Oncology|November 12, 2020
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 7, 2018
Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" populationJiri Minarik, Ludek Pour, Vladimir Maisnar, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|February 5, 2005
Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapyTomas Buchler, Marta Krejci, Adam Svobodnik, et al.
Cancers|July 9, 2020
Intercellular Mitochondrial Transfer in the Tumor MicroenvironmentHana Sahinbegovic, Tomas Jelinek, Matous Hrdinka, et al.
Targeted Oncology|October 12, 2020
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomibLudek Pour, Zdenek Adam, Lucie Buresova, et al.
Cancer|February 27, 2008
Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapyPieter Sonneveld, Roman Hajek, Arnon Nagler, et al.
Annals of Hematology|September 29, 2009
Levels of angiogenic factors in patients with multiple myeloma correlate with treatment responseLudek Pour, Hana Svachova, Zdenek Adam, et al.
Journal of Translational Medicine|March 26, 2013
Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myelomaElena Dementyeva, Fedor Kryukov, Lenka Kubiczkova, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patientsVlastimil Scudla, Jaroslav Bacovsky, Karel Indrak, et al.
Pageof 22